INFUSYSTEM HOLDINGS, INC Deferred Tax Liabilities, Gross
INFUSYSTEM HOLDINGS, INC (INFU) had Deferred Tax Liabilities, Gross of $8.50 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-27
- 2025-12-31: Deferred Tax Liabilities, Gross $8.50M.
- 2024-12-31: Deferred Tax Liabilities, Gross $7.27M.
- 2023-12-31: Deferred Tax Liabilities, Gross $6.97M.
- 2022-12-31: Deferred Tax Liabilities, Gross $6.86M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $8.50M 10-K · filed 2026-02-27 |
| 2024-12-31 | $7.27M 10-K · filed 2026-02-27 |
| 2023-12-31 | $6.97M 10-K · filed 2025-03-11 |
| 2022-12-31 | $6.86M 10-K · filed 2024-04-10 |
| 2016-12-31 | $6.63M 10-K · filed 2017-03-22 |
| 2015-12-31 | $5.15M 10-K · filed 2017-03-22 |
| 2014-12-31 | $3.58M 10-K/A · filed 2016-12-12 |
| 2013-12-31 | $2.71M 10-K · filed 2015-03-09 |
| 2012-12-31 | $3.94M 10-K · filed 2014-03-11 |
| 2011-12-31 | $3.94M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |